Evidence map›Paper›PMID 33294292›Full record

ArticleMolecular therapy. Nucleic acids2020

MicroRNA-22 Inhibits the Apoptosis of Vascular Smooth Muscle Cell by Targeting p38MAPKα in Vascular Remodeling of Aortic Dissection.

Yu Xiao, Yudong Sun, Xiang Ma, Chen Wang, Lei Zhang, Jiannan Wang, Guokun Wang, Zhenjiang Li, Wen Tian, Zhiqing Zhao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Non-coding RNAs Regulate the Pathogenesis of Aortic Dissection.Frontiers in cardiovascular medicine · 2022
    Review
  12. Article
  13. Article
  14. Challenges and strategies forBioactive materials · 2021
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Yu XiaoDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Yudong SunDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Xiang MaDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Chen WangInstitute of Health Sciences, Shanghai Jiao Tong University School of Medicine & Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, China.
Lei ZhangDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Jiannan WangDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Guokun WangInstitution of Cardiac Surgery, Department of Cardiovascular Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.
Zhenjiang LiDepartment of Vascular Surgery, The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, China.
Wen TianDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Zhiqing ZhaoDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Qing JingInstitute of Health Sciences, Shanghai Jiao Tong University School of Medicine & Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, China.
Jian ZhouDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Zaiping JingDepartment of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China.
Changhai Hospital · CNSecond Military Medical University · CNChinese Academy of Sciences · CNShanghai Jiao Tong University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA 22 (miR-22) was found in diverse cardiovascular diseases to have a role in regulating multiple cellular processes. However, the regulatory role of miR-22 in aortic dissection (AD) was still unclear. The miR-22 expression in human aorta was explored. A series of mimic, inhibitor, or small interfering RNA (siRNA) plasmids were delivered into vascular smooth muscle cells (VSMCs) to explore the effects of miR-22 and p38 mitogen-activated protein kinase α (p38MAPKα) in controlling VSMC apoptosis

Indexed as

aortic dissectionapoptosismicroRNA 22miR-22vascular remodelingvascular smooth muscle cell

Identifiers

PMID33294292
PMCPMC7691156
OpenAlexW3080908835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.